Study Details
Full Title
[C6461013] An Interventional Open-label Phase 1b/2 Study to Evaluate Safety, Pharmacokinetics, and Preliminary Efficacy of PF-08634404 as Monotherapy and Combination Therapy in Adult Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma
Principal Investigator
Michael
Morse
Protocol Number
PRO00119394
NCT ID
NCT07227012
Phase
I/II
Enrollment Status
Open to Enrollment